ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Blood Cells Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-25M9560
Home | Market Reports | Health| Medical Devices & Equipment
Global Artificial Blood Cells Market Research Report 2022
BUY CHAPTERS

Global Artificial Blood Cells Market Research Report 2025

Code: QYRE-Auto-25M9560
Report
February 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech

Artificial Blood Cells Market

The global market for Artificial Blood Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artificial Blood Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Cells.
The Artificial Blood Cells market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Blood Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Artificial Blood Cells Market Report

Report Metric Details
Report Name Artificial Blood Cells Market
Segment by Type
  • Animal Hemoglobin
  • Human Hemoglobin
  • Stem Cell
  • Others
Segment by Application
  • Cardiovascular Diseases
  • Anemia
  • Organ Transplant
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Artificial Blood Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Artificial Blood Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Artificial Blood Cells Market report?

Ans: The main players in the Artificial Blood Cells Market are Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech

What are the Application segmentation covered in the Artificial Blood Cells Market report?

Ans: The Applications covered in the Artificial Blood Cells Market report are Cardiovascular Diseases, Anemia, Organ Transplant, Others

What are the Type segmentation covered in the Artificial Blood Cells Market report?

Ans: The Types covered in the Artificial Blood Cells Market report are Animal Hemoglobin, Human Hemoglobin, Stem Cell, Others

1 Artificial Blood Cells Market Overview
1.1 Product Definition
1.2 Artificial Blood Cells by Type
1.2.1 Global Artificial Blood Cells Market Value Comparison by Type (2024 VS 2031)
1.2.2 Animal Hemoglobin
1.2.3 Human Hemoglobin
1.2.4 Stem Cell
1.2.5 Others
1.3 Artificial Blood Cells by Application
1.3.1 Global Artificial Blood Cells Market Value by Application (2024 VS 2031)
1.3.2 Cardiovascular Diseases
1.3.3 Anemia
1.3.4 Organ Transplant
1.3.5 Others
1.4 Global Artificial Blood Cells Market Size Estimates and Forecasts
1.4.1 Global Artificial Blood Cells Revenue 2020-2031
1.4.2 Global Artificial Blood Cells Sales 2020-2031
1.4.3 Global Artificial Blood Cells Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Artificial Blood Cells Market Competition by Manufacturers
2.1 Global Artificial Blood Cells Sales Market Share by Manufacturers (2020-2025)
2.2 Global Artificial Blood Cells Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Artificial Blood Cells Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Artificial Blood Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Blood Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Blood Cells, Product Type & Application
2.7 Global Key Manufacturers of Artificial Blood Cells, Date of Enter into This Industry
2.8 Global Artificial Blood Cells Market Competitive Situation and Trends
2.8.1 Global Artificial Blood Cells Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Artificial Blood Cells Players Market Share by Revenue
2.8.3 Global Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Blood Cells Market Scenario by Region
3.1 Global Artificial Blood Cells Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Artificial Blood Cells Sales by Region: 2020-2031
3.2.1 Global Artificial Blood Cells Sales by Region: 2020-2025
3.2.2 Global Artificial Blood Cells Sales by Region: 2026-2031
3.3 Global Artificial Blood Cells Revenue by Region: 2020-2031
3.3.1 Global Artificial Blood Cells Revenue by Region: 2020-2025
3.3.2 Global Artificial Blood Cells Revenue by Region: 2026-2031
3.4 North America Artificial Blood Cells Market Facts & Figures by Country
3.4.1 North America Artificial Blood Cells Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Artificial Blood Cells Sales by Country (2020-2031)
3.4.3 North America Artificial Blood Cells Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Blood Cells Market Facts & Figures by Country
3.5.1 Europe Artificial Blood Cells Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Artificial Blood Cells Sales by Country (2020-2031)
3.5.3 Europe Artificial Blood Cells Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Blood Cells Market Facts & Figures by Region
3.6.1 Asia Pacific Artificial Blood Cells Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Artificial Blood Cells Sales by Region (2020-2031)
3.6.3 Asia Pacific Artificial Blood Cells Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Blood Cells Market Facts & Figures by Country
3.7.1 Latin America Artificial Blood Cells Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Artificial Blood Cells Sales by Country (2020-2031)
3.7.3 Latin America Artificial Blood Cells Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Blood Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Blood Cells Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Artificial Blood Cells Sales by Country (2020-2031)
3.8.3 Middle East and Africa Artificial Blood Cells Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artificial Blood Cells Sales by Type (2020-2031)
4.1.1 Global Artificial Blood Cells Sales by Type (2020-2025)
4.1.2 Global Artificial Blood Cells Sales by Type (2026-2031)
4.1.3 Global Artificial Blood Cells Sales Market Share by Type (2020-2031)
4.2 Global Artificial Blood Cells Revenue by Type (2020-2031)
4.2.1 Global Artificial Blood Cells Revenue by Type (2020-2025)
4.2.2 Global Artificial Blood Cells Revenue by Type (2026-2031)
4.2.3 Global Artificial Blood Cells Revenue Market Share by Type (2020-2031)
4.3 Global Artificial Blood Cells Price by Type (2020-2031)
5 Segment by Application
5.1 Global Artificial Blood Cells Sales by Application (2020-2031)
5.1.1 Global Artificial Blood Cells Sales by Application (2020-2025)
5.1.2 Global Artificial Blood Cells Sales by Application (2026-2031)
5.1.3 Global Artificial Blood Cells Sales Market Share by Application (2020-2031)
5.2 Global Artificial Blood Cells Revenue by Application (2020-2031)
5.2.1 Global Artificial Blood Cells Revenue by Application (2020-2025)
5.2.2 Global Artificial Blood Cells Revenue by Application (2026-2031)
5.2.3 Global Artificial Blood Cells Revenue Market Share by Application (2020-2031)
5.3 Global Artificial Blood Cells Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dextro-Sang Corporation
6.1.1 Dextro-Sang Corporation Company Information
6.1.2 Dextro-Sang Corporation Description and Business Overview
6.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dextro-Sang Corporation Artificial Blood Cells Product Portfolio
6.1.5 Dextro-Sang Corporation Recent Developments/Updates
6.2 BioPure Corporation
6.2.1 BioPure Corporation Company Information
6.2.2 BioPure Corporation Description and Business Overview
6.2.3 BioPure Corporation Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioPure Corporation Artificial Blood Cells Product Portfolio
6.2.5 BioPure Corporation Recent Developments/Updates
6.3 Sangart
6.3.1 Sangart Company Information
6.3.2 Sangart Description and Business Overview
6.3.3 Sangart Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sangart Artificial Blood Cells Product Portfolio
6.3.5 Sangart Recent Developments/Updates
6.4 Northfield Laboratories
6.4.1 Northfield Laboratories Company Information
6.4.2 Northfield Laboratories Description and Business Overview
6.4.3 Northfield Laboratories Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Northfield Laboratories Artificial Blood Cells Product Portfolio
6.4.5 Northfield Laboratories Recent Developments/Updates
6.5 Baxter International
6.5.1 Baxter International Company Information
6.5.2 Baxter International Description and Business Overview
6.5.3 Baxter International Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Baxter International Artificial Blood Cells Product Portfolio
6.5.5 Baxter International Recent Developments/Updates
6.6 Dentritech
6.6.1 Dentritech Company Information
6.6.2 Dentritech Description and Business Overview
6.6.3 Dentritech Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dentritech Artificial Blood Cells Product Portfolio
6.6.5 Dentritech Recent Developments/Updates
6.7 FluorO2 Therapeutics
6.7.1 FluorO2 Therapeutics Company Information
6.7.2 FluorO2 Therapeutics Description and Business Overview
6.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.7.4 FluorO2 Therapeutics Artificial Blood Cells Product Portfolio
6.7.5 FluorO2 Therapeutics Recent Developments/Updates
6.8 Nuvox Pharma
6.8.1 Nuvox Pharma Company Information
6.8.2 Nuvox Pharma Description and Business Overview
6.8.3 Nuvox Pharma Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nuvox Pharma Artificial Blood Cells Product Portfolio
6.8.5 Nuvox Pharma Recent Developments/Updates
6.9 Alpha Therapeutic Corporation
6.9.1 Alpha Therapeutic Corporation Company Information
6.9.2 Alpha Therapeutic Corporation Description and Business Overview
6.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolio
6.9.5 Alpha Therapeutic Corporation Recent Developments/Updates
6.10 HemoBioTech
6.10.1 HemoBioTech Company Information
6.10.2 HemoBioTech Description and Business Overview
6.10.3 HemoBioTech Artificial Blood Cells Sales, Revenue and Gross Margin (2020-2025)
6.10.4 HemoBioTech Artificial Blood Cells Product Portfolio
6.10.5 HemoBioTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Blood Cells Industry Chain Analysis
7.2 Artificial Blood Cells Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Blood Cells Production Mode & Process Analysis
7.4 Artificial Blood Cells Sales and Marketing
7.4.1 Artificial Blood Cells Sales Channels
7.4.2 Artificial Blood Cells Distributors
7.5 Artificial Blood Cells Customer Analysis
8 Artificial Blood Cells Market Dynamics
8.1 Artificial Blood Cells Industry Trends
8.2 Artificial Blood Cells Market Drivers
8.3 Artificial Blood Cells Market Challenges
8.4 Artificial Blood Cells Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
List of Tables
 Table 1. Global Artificial Blood Cells Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Artificial Blood Cells Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Artificial Blood Cells Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Artificial Blood Cells Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Artificial Blood Cells Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Artificial Blood Cells Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Artificial Blood Cells Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Artificial Blood Cells Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Artificial Blood Cells, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Artificial Blood Cells, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Artificial Blood Cells, Product Type & Application
 Table 12. Global Key Manufacturers of Artificial Blood Cells, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Artificial Blood Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Cells as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Artificial Blood Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Artificial Blood Cells Sales by Region (2020-2025) & (K Units)
 Table 18. Global Artificial Blood Cells Sales Market Share by Region (2020-2025)
 Table 19. Global Artificial Blood Cells Sales by Region (2026-2031) & (K Units)
 Table 20. Global Artificial Blood Cells Sales Market Share by Region (2026-2031)
 Table 21. Global Artificial Blood Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Artificial Blood Cells Revenue Market Share by Region (2020-2025)
 Table 23. Global Artificial Blood Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Artificial Blood Cells Revenue Market Share by Region (2026-2031)
 Table 25. North America Artificial Blood Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
 Table 27. North America Artificial Blood Cells Sales by Country (2026-2031) & (K Units)
 Table 28. North America Artificial Blood Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Artificial Blood Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Artificial Blood Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Artificial Blood Cells Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Artificial Blood Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Artificial Blood Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Artificial Blood Cells Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Artificial Blood Cells Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Artificial Blood Cells Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Artificial Blood Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Artificial Blood Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Artificial Blood Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Artificial Blood Cells Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Artificial Blood Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Artificial Blood Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Artificial Blood Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Artificial Blood Cells Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Artificial Blood Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Artificial Blood Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Artificial Blood Cells Sales (K Units) by Type (2020-2025)
 Table 51. Global Artificial Blood Cells Sales (K Units) by Type (2026-2031)
 Table 52. Global Artificial Blood Cells Sales Market Share by Type (2020-2025)
 Table 53. Global Artificial Blood Cells Sales Market Share by Type (2026-2031)
 Table 54. Global Artificial Blood Cells Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Artificial Blood Cells Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Artificial Blood Cells Revenue Market Share by Type (2020-2025)
 Table 57. Global Artificial Blood Cells Revenue Market Share by Type (2026-2031)
 Table 58. Global Artificial Blood Cells Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Artificial Blood Cells Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Artificial Blood Cells Sales (K Units) by Application (2020-2025)
 Table 61. Global Artificial Blood Cells Sales (K Units) by Application (2026-2031)
 Table 62. Global Artificial Blood Cells Sales Market Share by Application (2020-2025)
 Table 63. Global Artificial Blood Cells Sales Market Share by Application (2026-2031)
 Table 64. Global Artificial Blood Cells Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Artificial Blood Cells Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Artificial Blood Cells Revenue Market Share by Application (2020-2025)
 Table 67. Global Artificial Blood Cells Revenue Market Share by Application (2026-2031)
 Table 68. Global Artificial Blood Cells Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Artificial Blood Cells Price (US$/Unit) by Application (2026-2031)
 Table 70. Dextro-Sang Corporation Company Information
 Table 71. Dextro-Sang Corporation Description and Business Overview
 Table 72. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Dextro-Sang Corporation Artificial Blood Cells Product
 Table 74. Dextro-Sang Corporation Recent Developments/Updates
 Table 75. BioPure Corporation Company Information
 Table 76. BioPure Corporation Description and Business Overview
 Table 77. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BioPure Corporation Artificial Blood Cells Product
 Table 79. BioPure Corporation Recent Developments/Updates
 Table 80. Sangart Company Information
 Table 81. Sangart Description and Business Overview
 Table 82. Sangart Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sangart Artificial Blood Cells Product
 Table 84. Sangart Recent Developments/Updates
 Table 85. Northfield Laboratories Company Information
 Table 86. Northfield Laboratories Description and Business Overview
 Table 87. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Northfield Laboratories Artificial Blood Cells Product
 Table 89. Northfield Laboratories Recent Developments/Updates
 Table 90. Baxter International Company Information
 Table 91. Baxter International Description and Business Overview
 Table 92. Baxter International Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Baxter International Artificial Blood Cells Product
 Table 94. Baxter International Recent Developments/Updates
 Table 95. Dentritech Company Information
 Table 96. Dentritech Description and Business Overview
 Table 97. Dentritech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dentritech Artificial Blood Cells Product
 Table 99. Dentritech Recent Developments/Updates
 Table 100. FluorO2 Therapeutics Company Information
 Table 101. FluorO2 Therapeutics Description and Business Overview
 Table 102. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. FluorO2 Therapeutics Artificial Blood Cells Product
 Table 104. FluorO2 Therapeutics Recent Developments/Updates
 Table 105. Nuvox Pharma Company Information
 Table 106. Nuvox Pharma Description and Business Overview
 Table 107. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Nuvox Pharma Artificial Blood Cells Product
 Table 109. Nuvox Pharma Recent Developments/Updates
 Table 110. Alpha Therapeutic Corporation Company Information
 Table 111. Alpha Therapeutic Corporation Description and Business Overview
 Table 112. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Alpha Therapeutic Corporation Artificial Blood Cells Product
 Table 114. Alpha Therapeutic Corporation Recent Developments/Updates
 Table 115. HemoBioTech Company Information
 Table 116. HemoBioTech Description and Business Overview
 Table 117. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. HemoBioTech Artificial Blood Cells Product
 Table 119. HemoBioTech Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Artificial Blood Cells Distributors List
 Table 123. Artificial Blood Cells Customers List
 Table 124. Artificial Blood Cells Market Trends
 Table 125. Artificial Blood Cells Market Drivers
 Table 126. Artificial Blood Cells Market Challenges
 Table 127. Artificial Blood Cells Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Artificial Blood Cells
 Figure 2. Global Artificial Blood Cells Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Artificial Blood Cells Market Share by Type: 2024 & 2031
 Figure 4. Animal Hemoglobin Product Picture
 Figure 5. Human Hemoglobin Product Picture
 Figure 6. Stem Cell Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Artificial Blood Cells Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Artificial Blood Cells Market Share by Application: 2024 & 2031
 Figure 10. Cardiovascular Diseases
 Figure 11. Anemia
 Figure 12. Organ Transplant
 Figure 13. Others
 Figure 14. Global Artificial Blood Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Artificial Blood Cells Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Artificial Blood Cells Sales (2020-2031) & (K Units)
 Figure 17. Global Artificial Blood Cells Average Price (US$/Unit) & (2020-2031)
 Figure 18. Artificial Blood Cells Report Years Considered
 Figure 19. Artificial Blood Cells Sales Share by Manufacturers in 2024
 Figure 20. Global Artificial Blood Cells Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Artificial Blood Cells Players: Market Share by Revenue in Artificial Blood Cells in 2024
 Figure 22. Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Artificial Blood Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Artificial Blood Cells Sales Market Share by Country (2020-2031)
 Figure 25. North America Artificial Blood Cells Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Artificial Blood Cells Sales Market Share by Country (2020-2031)
 Figure 29. Europe Artificial Blood Cells Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Artificial Blood Cells Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Artificial Blood Cells Revenue Market Share by Region (2020-2031)
 Figure 37. China Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Artificial Blood Cells Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Artificial Blood Cells Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Artificial Blood Cells Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Artificial Blood Cells Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Artificial Blood Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Artificial Blood Cells by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Artificial Blood Cells by Type (2020-2031)
 Figure 59. Global Artificial Blood Cells Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Artificial Blood Cells by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Artificial Blood Cells by Application (2020-2031)
 Figure 62. Global Artificial Blood Cells Price (US$/Unit) by Application (2020-2031)
 Figure 63. Artificial Blood Cells Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Artificial Blood Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Based Artificial Meat Market Research Report 2025
Global Artificial Organs Market Research Report 2024
Global Artificial Blood Substitute Market Research Report 2024
Global Artificial Platelet Market Research Report 2025
Global Artificial Organ and Tissues Market Research Report 2025
Synthetic Blood Substitutes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthetic Artificial Blood Vessels Market Research Report 2025
Global Artificial Lung Devices Market Research Report 2024
Medical Artificial Blood Vessel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biocomposite Artificial Blood Vessels Market Research Report 2024
Global Stem Cell Artificial Meat Market Research Report 2020
Global Artificial Heart Transplant Market Research Report 2024
Global Digital Blood Cell Counter Market Research Report 2025
Global Artificial Plant Market Research Report 2025
Blood Substitute Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Automated Complete Blood Cell Counter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Bone Market Research Report 2024
Global Disposable Blood Transfusion Market Research Report 2025
Medical Artificial Organs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions